PreOmics GmbH announced that it has received 13,500,000 in an equity round of funding on January 19, 2022. The transaction included participation from Bruker Corporation for majority stake in the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
70.04 USD | -0.06% | -13.49% | -4.67% |
02/05 | Bruker Shares Fall After Q1 Revenue Misses Consensus Views; Lifts Full-Year Guidance | MT |
02/05 | Transcript : Bruker Corporation, Q1 2024 Earnings Call, May 02, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.67% | 10.18B | |
+7.84% | 218B | |
+7.35% | 184B | |
+13.04% | 135B | |
+26.03% | 107B | |
-1.33% | 62.38B | |
+11.80% | 51.37B | |
+4.81% | 50.9B | |
+0.30% | 40.87B | |
+2.78% | 36.28B |
- Stock Market
- Equities
- BRKR Stock
- News Bruker Corporation
- PreOmics GmbH announced that it has received €13.5 million in funding from Bruker Corporation